Bruce E. Sands

Genetics · 2004–2020

A researcher in the Science corpus: 17 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom Bruce E. Sands trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. W. Sandborn

Who trusts Bruce E. Sands overall

  1. W. Sandborn
  2. Markus F. Neurath

Papers from Bruce E. Sands's perspective

Ordered by how strongly the researchers Bruce E. Sands trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. (Gastroenterology)
  2. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. (Gastroenterology)
  3. Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee (American Journal of Gastroenterology)
  4. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. (Gastroenterology)
  5. Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease. (Clinical Gastroenterology and Hepatology)
  6. Inflammatory bowel disease: clinical aspects and established and evolving therapies (The Lancet)
  7. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease (Nature Genetics)
  8. A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene (Science)
  9. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial. (The Lancet)
  10. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 (Nature Genetics)

Their papers